PREMIX DRUG PRODUCT OF EDARAVONE
PROBLEM TO BE SOLVED: To provide a premix drug product of edaravone excellent in moldability and storage stability. SOLUTION: The premix drug product of the edaravone is formed of a multilayer film or multilayer sheet including a barrier layer with a thickness of 10 to 80 μm containing a cyclic poly...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To provide a premix drug product of edaravone excellent in moldability and storage stability. SOLUTION: The premix drug product of the edaravone is formed of a multilayer film or multilayer sheet including a barrier layer with a thickness of 10 to 80 μm containing a cyclic polyolefin resin having a glass transition point of 70 to 110°C as a main component and a seal layer of a thickness of 5 to 80 μm arranged adjacent to the barrier layer and containing a polypropylene-based resin as a main component, wherein the seal layer forms the innermost layer, an aqueous drug product including the edaravone is accommodated in a plastic container having a seal portion sealed by seal layers facing each other, and the premix drug product of the edaravone is constituted by subjecting the same to high pressure steam sterilization in a hermetically sealed condition. COPYRIGHT: (C)2010,JPO&INPIT |
---|